Yang Tianxin, Xu Chuanming
Internal Medicine, University of Utah and Veterans Affairs Medical Center, Salt Lake City, Utah; and
Institute of Hypertension, Sun Yat-sen University School of Medicine, Guangzhou, China.
J Am Soc Nephrol. 2017 Apr;28(4):1040-1049. doi: 10.1681/ASN.2016070734. Epub 2017 Mar 2.
The renin-angiotensin system (RAS) has a pivotal role in the maintenance of extracellular volume homeostasis and blood pressure through complex mechanisms. Apart from the well known systemic RAS, occurrence of a local RAS has been documented in multiple tissues, including the kidney. A large body of recent evidence from pharmacologic and genetic studies, particularly those using various transgenic approaches to manipulate intrarenal levels of RAS components, has established the important role of intrarenal RAS in hypertension. Recent studies have also begun to unravel the molecular mechanisms that govern intrarenal RAS activity. This local system is under the control of complex regulatory networks consisting of positive regulators of (pro)renin receptor, Wnt/-catenin signaling, and PGE/PGE receptor EP subtype, and negative regulators of Klotho, vitamin D receptor, and liver X receptors. This review highlights recent advances in defining the regulation and function of intrarenal RAS as a unique entity separate from systemic angiotensin II generation.
肾素-血管紧张素系统(RAS)通过复杂机制在维持细胞外液容量稳态和血压方面发挥关键作用。除了众所周知的全身RAS外,在包括肾脏在内的多个组织中已证实存在局部RAS。来自药理学和遗传学研究的大量最新证据,特别是那些使用各种转基因方法来操纵肾脏内RAS成分水平的研究,已经确立了肾脏内RAS在高血压中的重要作用。最近的研究也开始揭示控制肾脏内RAS活性的分子机制。这个局部系统受复杂调控网络的控制,该网络由(前)肾素受体的正调控因子、Wnt/β-连环蛋白信号通路和前列腺素E/前列腺素E受体EP亚型,以及Klotho、维生素D受体和肝脏X受体的负调控因子组成。本综述重点介绍了在将肾脏内RAS的调控和功能定义为与全身血管紧张素II生成分开的独特实体方面的最新进展。